Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bosar Se is a nano-sized organic selenium (yeast selenium) feed additive developed by Yunnan Bosar Biotechnology and Guangzhou Haicheng Pharmaceutical (HC Pharma). It is designed to combat oxidative stress in livestock, poultry, and aquatic animals by neutralizing free radicals and improving antioxidant enzyme activity. Bosar Se stands out with its low toxicity, high bioavailability, and superior absorption rate compared to inorganic selenium. It is used to improve animal immune function, enhance reproductive capacity, prevent stress syndrome, and improve meat quality.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bosar Se.